Herpin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Herpin

Property Description
Active ingredient Aciclovir (Acyclovir)
Form Tablet, Suspension, Cream, Injection, Ophthalmic Ointment
Pharmacological class Antiviral Drug / Selective Antiviral Agent
General Purpose To limit the proliferation and spread of target viruses
Origin Synthetic Purine Nucleoside Analog

What Type of Medicine is Herpin (Aciclovir)?

Herpin is a prescription-only medicine (Rx) containing the single active ingredient, Aciclovir (also known as Acyclovir), which is classified as an antiviral drug. This substance is a purine nucleoside analog and a selective antiviral agent. Its identity is rooted in its origin as a synthetic compound, rather than being derived from a natural source. The high-level composition of the final drug involves the Aciclovir compound combined with pharmaceutical excipients necessary for stable formulation. The INN (Aciclovir) is widely associated with the original brand, Zovirax, highlighting its foundational status in this therapeutic class.

What is the General Purpose of This Antiviral Drug?

The general purpose of Aciclovir is to limit the overall presence and severity of a viral infection by disrupting the virus's ability to reproduce. It achieves this by functioning as a highly specific DNA polymerase inhibitor. The medicine serves as an agent for managing viral multiplication, and Aciclovir is fundamentally recognized for its benefit in limiting the spread of the virus throughout the body, such as during the initial appearance of an outbreak. The drug is designed to target only cells that are actively infected, resulting in the termination of viral DNA synthesis.

How is Aciclovir Supplied (Dosage Forms)?

Aciclovir is supplied in a variety of drug forms to enable both systemic administration and topical administration, depending on the site of infection. These preparations include the tablet and oral suspension for systemic treatment, as well as localized forms like the cream and ophthalmic ointment for use on the skin or eye. A formulation for intravenous injection is also available for more severe systemic applications. The availability of multiple forms ensures that the active ingredient can be delivered effectively to the necessary tissues, whether external or internal, which is a key characteristic separating it from topical-only antiviral agents.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Herpin?

Possible Side Effects

Herpin (Idoxuridine) is generally well-tolerated, but like all medications, it can cause side effects. These are typically mild and localized when the drug is used as an ophthalmic (eye) preparation, but you should consult your doctor if any side effects are persistent or concerning.

Common Ocular Side Effects

The most frequently reported side effects are associated with irritation at the application site and may include:

Side Effect Category Examples
Local Irritation Mild stinging, burning, or itching of the eye or eyelid.
Appearance Changes Redness (hyperemia) or swelling (edema) of the eye or eyelid.
Visual/Light Sensitivity Increased sensitivity to light (photophobia); temporary blurred vision immediately following application.
Other Excess flow of tears.

Less Common and Serious Effects

Less common side effects can involve corneal changes. Prolonged use has been associated with more serious adverse effects such as corneal epithelial damage, superficial punctate keratitis (tiny lesions on the cornea), and corneal clouding. Contact your healthcare provider immediately if you experience worsening vision, severe eye pain, or a severe increase in irritation/redness.

Safety Information and Precautions

  • Allergies: Do not use Herpin if you have a known hypersensitivity or allergy to idoxuridine or any of its components.
  • Pregnancy and Breastfeeding: Consult your doctor before using this medication if you are pregnant, planning to become pregnant, or breastfeeding. Its safety in these situations is not fully established.
  • Driving/Operating Machinery: Since temporary blurred vision or light sensitivity can occur, exercise caution when driving or operating machinery until your vision clears.
  • Use Duration: This medicine is typically not for long-term use. Follow your doctor's prescribed duration exactly to avoid potential complications and drug resistance.

Overdose and Emergency Response

The official regulatory documents state that an overdosage of Herpin (Aciclovir) requires immediate medical attention and may lead to serious systemic effects primarily affecting the Central Nervous System (CNS) and the renal system.

Documented Clinical Signs

Overdose is characterized by a spectrum of neurological symptoms, including confusion, agitation, hallucinations, and somnolence, which may escalate to seizures or coma. Gastrointestinal effects such as nausea and vomiting are also documented. Renal impairment is a serious outcome, indicated by elevations of serum creatinine and blood urea nitrogen (BUN), and a decrease in urination. Overexposure, particularly via intravenous administration, has specifically resulted in subsequent acute renal failure.

Mandated Emergency Response

Regulatory authorities mandate that immediate medical attention must be sought for any suspected overdosage. If an individual has collapsed, experienced a seizure, or is otherwise unresponsive, emergency services must be contacted immediately. Patients must be observed closely for signs of toxicity. Management is defined as symptomatic and supportive care. Haemodialysis is documented as a procedure that significantly enhances the removal of the drug from the bloodstream and may be considered a key management option. Official labeling highlights that elderly patients and individuals with impaired renal function are at an increased risk of developing neurological toxicity.

Therapeutic Uses of Herpin

What Herpin Treats: Main Uses and Benefits

Quick Facts

  • May offer management for symptoms associated with various conditions.
  • Used to help address severe discomfort in a clinical setting.
  • May be administered to support palliative care needs.

Herpin (diamorphine) is a medication utilized in specific clinical environments. Its primary use may help manage severe pain associated with a range of conditions, which can include instances of severe physical trauma or myocardial infarction (heart attack). This medication is also used to address acute and chronic discomfort, such as pain experienced following major surgery or discomfort related to terminal illnesses and palliative care needs.

In some countries, it may be considered when other pain management approaches do not provide sufficient symptom relief. The therapeutic role of Herpin is to help modify the patient's experience of pain. In certain regions, diamorphine is classified as a controlled substance with no approved indications for medical use. However, under the generic name diamorphine, it is utilized as a prescription analgesic in other jurisdictions for the management of severe, acute, and chronic pain situations.

Eligibility and Restrictions for Use

Who can and cannot use Herpin?

Eligibility for Herpin (Aciclovir) is defined by official government regulatory documents based on patient health status and life stage. The medicine is primarily approved for adults and children who do not have specific contraindications or conditions requiring restriction.


Absolute Contraindications

Herpin is contraindicated (must not be used) in patients with a clinically significant hypersensitivity (allergic reaction) to aciclovir, valaciclovir, or any component of the formulation. It is also prohibited for individuals with a history of developing Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome, following prior use of aciclovir or valaciclovir.

Restricted and Conditional Use

  • Renal Impairment: Patients with impaired renal function require close monitoring and often necessitate a dosage adjustment, as Aciclovir is primarily eliminated by the kidneys.
  • Geriatric Patients: Elderly patients are at an increased risk of neurological effects due to likely age-related reduction in renal function, requiring caution and potentially dosage reduction.
  • Age-Specific Limitations: The safety and effectiveness of the ophthalmic ointment formulation have not been established in pediatric patients under the age of two years.
  • Pregnancy and Lactation: Use during pregnancy is recommended only if the potential benefits outweigh the potential risks. Caution is advised when administering the drug to a nursing woman, as Aciclovir is known to pass into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Herpin (aciclovir) is primarily eliminated unchanged through the kidneys via active renal tubular secretion. Consequently, documented interactions center on substances that interfere with this clearance pathway or that create a cumulative toxicity risk, as formally detailed in regulatory information.

Interaction Scope

Category Official Regulatory Statement
Medicinal product categories Agents that compete for active renal tubular secretion; potentially nephrotoxic agents.
Specific interacting medicines Probenecid, Cimetidine, Mycophenolate Mofetil (MMF), Theophylline, Zidovudine.
Mechanistic basis Competitive inhibition of active renal tubular secretion (a pharmacokinetic mechanism); cumulative toxicity risk (a pharmacodynamic mechanism).
Population-specific notes Geriatric patients and individuals with underlying renal impairment are documented to have higher Aciclovir plasma concentrations. This elevated baseline exposure must be considered during co-administration of interacting drugs.

Official Interaction Statements:

Co-administration with Probenecid and Cimetidine reduces Aciclovir's renal clearance, officially resulting in elevated systemic plasma concentrations and Area Under the Concentration-Time Curve (AUC).

A mutual increase in AUC is documented with MMF, affecting both Aciclovir and the MMF inactive metabolite. Furthermore, Aciclovir increases the AUC of Theophylline by approximately 50%, a change that officially requires monitoring of Theophylline concentrations during co-therapy.

A cumulative toxicity risk is noted with potentially nephrotoxic agents due to the increased potential for renal dysfunction. The combined use of Aciclovir and Zidovudine is associated with reports of severe lethargy and confusion.

Mechanism of Action

Intracellular Activation and Obligate Chain Termination

Aciclovir is a purine nucleoside analog that is initially inert and requires a unique, enzyme-dependent activation. The molecule must first be phosphorylated by Viral Thymidine Kinase ( vTK), an enzyme produced specifically by the target herpes viruses inside the infected cell. This process ensures the active form, Aciclovir triphosphate ( Acyclo-GTP), is preferentially generated within viral replication sites, a property known as bio-selectivity.

Once activated, Acyclo-GTP functions as both a competitive inhibitor and an obligate chain terminator of the Viral DNA Polymerase. It binds to the enzyme, displacing the natural substrate, and upon incorporation into the nascent viral DNA chain, it lacks the necessary chemical structure (the 3'-hydroxyl group) to attach further nucleotides. This action irreversibly halts DNA synthesis. This block in replication at the cellular level results in the physiological consequence of limiting the overall proliferation and spread of the virus throughout the affected tissues.

The drug's action is fundamentally constrained by its dependence on vTK. It is mechanistically ineffective against dormant (latent) viral DNA residing in nerve cells, as vTK is not present. Strains of the virus developing an altered or deficient vTK are resistant, as they cannot convert the drug to its active form, nullifying the mechanism.

Dosage and Administration Information

Herpin, which contains the active ingredient Aciclovir, is administered via multiple distinct routes to deliver treatment appropriate to the site of infection. These routes include oral administration (tablets, capsules, or suspension), intravenous (IV) injection for more severe systemic use, topical cream for localized skin lesions, and ophthalmic ointment for eye infections.

The dosing schedule establishes two primary frequency patterns. For the acute treatment of conditions like Herpes Zoster, the oral regimen is typically 800 mg five times daily. Conversely, the long-term chronic suppressive therapy for recurrent disease commonly utilizes a lower frequency, such as 400 mg twice daily. Acute courses have a defined duration, often ranging from 5 to 10 days, and effectiveness is tied to prompt initiation of therapy.

Regarding administration conditions, oral doses are permitted to be taken with or without food. A procedural instruction involves maintaining adequate hydration, especially for patients receiving high oral doses or IV treatment, to support proper clearance. Population-specific rules involve dose adjustment in patients with renal impairment, determined by their creatinine clearance. Older adults may also require dosage modification due to the likelihood of reduced kidney function, while children under two years are typically given half the adult dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Herpin (Aciclovir)


Evidence for Use in Herpes Simplex Virus (HSV) Infections (Non-Genital and Genital)

The research on Herpin (Aciclovir) for managing Herpes Simplex Virus (HSV) infections has primarily relied on Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies monitored outcomes related to physical discomfort, such as the time until lesions crusted or healed and patient-reported pain scores. Studies monitored the time to healing, reporting patterns where treatment was associated with a shorter measured time compared to control groups. Research has also explored the use of the medicine as a suppressive therapy administered daily. Findings indicate that continuous use was studied for its association with patterns of recurrence during the study period.

Research indicates that the studies did not evaluate the eradication of the virus in its latent state; therefore, the risk of recurrence may continue after treatment is stopped. Furthermore, the long-term development of resistance to Aciclovir, particularly in patients who use it frequently, is not yet fully established in extensive, long-term studies.


Evidence for Use in Varicella-Zoster Virus (VZV) Infections (Shingles)

Herpin was evaluated in studies for VZV infections, focusing on rash resolution and the severity of acute pain. Research also examined long-term outcomes by monitoring the potential for the long-term complication known as Post-Herpetic Neuralgia (PHN). Studies report how symptoms evolved in the observed populations, indicating that early treatment initiation was associated with a shorter duration of rash crusting and time until pain relief was reported.

A critical area of uncertainty relates to the minimal change documented in research regarding long-term outcomes related to PHN following shingles. Research describes that the studies do not determine whether an individual will respond similarly to the study endpoints, and studies are still exploring better ways to manage this long-term pain. The long-term effects of daily use and the pattern of viral resistance are areas where research is ongoing.

Key Studies & References

  1. Acyclovir - StatPearls - NCBI Bookshelf (Review of indications and general evidence)

Frequently Asked Questions (FAQ)

Common questions about Herpin (FAQ)


Q: Is Herpin the same kind of medicine as other treatments for the same condition?

A: Herpin (aciclovir) is officially classified as a synthetic purine nucleoside analogue and a selective antiviral agent. The way it works is highly selective: it requires activation by a specific enzyme produced only inside the virus-infected cell. This targeted action is one characteristic that separates it from other potential drug classes used for similar conditions.


Q: What are the most commonly reported side effects of Herpin?

A: For the oral formulations of Herpin, official regulatory documents report common side effects such as headache, dizziness, nausea, vomiting, diarrhoea, abdominal pains, and various skin reactions like rashes or itching. A comprehensive listing of potential effects is typically available in the official prescribing information.


Q: Can Herpin be taken with common over-the-counter pain relievers?

A: Regulatory documents do not list specific, common over-the-counter (OTC) pain relievers as formal, interacting agents. However, official information does advise caution when Herpin is co-administered with any medicine that is eliminated by the kidneys or that has the potential for causing kidney dysfunction (known as nephrotoxic agents).


Q: What happens when you stop taking Herpin?

A: Studies and official information indicate that Herpin does not eliminate the virus in its dormant state, which is why the infection can reappear. For individuals using the medicine long-term to prevent outbreaks, official studies suggest that the frequency and severity of viral recurrences may return to the patterns experienced before treatment was discontinued.


Q: Are there different strengths of Herpin available?

A: Yes, Herpin (aciclovir) is officially available in multiple formulations to suit different uses, including oral tablets in strengths of 200 mg, 400 mg, and 800 mg. It is also available as an oral suspension, topical cream, ophthalmic ointment (for the eye), and a solution for injection.


Q: Can Herpin be used by people with a history of liver problems?

A: Herpin is primarily removed from the body by the kidneys and is not extensively processed by the liver. Official documents recommend that caution should be exercised when using the medicine in patients who have pre-existing severe hepatic (liver) abnormalities.


Q: Do I need to keep taking Herpin even if I feel better?

A: Official dosing guidelines for acute treatment courses (short-term use for an active outbreak) specify a defined duration, usually lasting several days. Regulatory information emphasizes that the treatment is most effective when the full prescribed course is completed, even if symptom relief is experienced.


Q: Is it true that Herpin can interact with certain foods?

A: Official administration instructions for oral Herpin state that the medicine can be taken with or without food. No specific food restrictions or interactions are listed in the regulatory documents.


Q: How long does it typically take before I might notice the effect of Herpin?

A: Official clinical studies on conditions like shingles and chickenpox noted that early treatment initiation was associated with a shorter time until lesions crusted and healed, and the time until pain relief was reported. The drug is described as being most effective when treatment starts as soon as possible after the outbreak begins.


Q: Is Herpin safe for use by older adults?

A: Herpin is described for use in older adults in official documents. Due to the potential for reduced kidney function in this population, a dosage adjustment is often necessary, and close monitoring for neurological effects is described as important.


Q: Are there any specific safety warnings listed for Herpin use in children?

A: Official information states that the safety and effectiveness of the ophthalmic (eye) ointment formulation are not established for use in children under the age of two years. For other approved uses in children, a dose is generally calculated based on age and weight.


Q: Why is Herpin sometimes referred to by a different name?

A: The active ingredient in Herpin is formally known by its chemical name, aciclovir, or the equivalent name acyclovir in some regions. It is referred to by these different names based on the specific brand name or the country's official regulatory listing.


Q: Does taking Herpin affect your ability to drive or operate machinery?

A: Official information advises caution because certain side effects, such as dizziness, confusion, or visual changes, are known to occur. Official guidance states that caution is necessary, and the potential for side effects should be considered before driving or operating machinery.


Q: Can Herpin be crushed or split if it is a tablet?

A: Official patient information generally instructs against cutting or crushing the oral tablet formulation. Official documents describe that an oral suspension formulation may be available as an alternative.


Q: Why do some people experience mild dizziness with Herpin?

A: Official product information lists dizziness as a common adverse reaction for people taking oral Herpin. This effect is described as being related to the nervous system and is detailed among the common side effects.


Q: Is it common to feel tired when starting Herpin?

A: Official regulatory documents do not list fatigue or tiredness as a common side effect of oral Herpin. However, some official sources do list general weakness as a commonly reported side effect.


Q: What if I drink alcohol while taking Herpin?

A: There is no formal drug interaction listed between Herpin (aciclovir) and alcohol in official regulatory documents. However, it is advised that the potential for side effects, such as dizziness or confusion, be considered, as these effects might be worsened by alcohol use.


Q: How is Herpin absorbed by the body?

A: According to official pharmacokinetic descriptions, Herpin is only partially absorbed from the gut when taken orally. The typical oral bioavailability (the amount that reaches the bloodstream) in adults is described as low, usually ranging from 10 % to 20 %, and this amount can decrease as the size of the dose increases.


Q: Is Herpin a controlled substance?

A: Herpin (aciclovir) is officially classified as a prescription-only medicine (Rx) by regulatory bodies. It is not listed as a controlled substance under the regulatory scheduling systems in the United States.


Q: Can Herpin be taken by someone who has kidney disease?

A: Herpin is described for use in people with kidney disease, but regulatory documents mandate specific measures and warnings. Because the medicine is eliminated by the kidneys, a dosage reduction, based on the degree of kidney impairment, is necessary to prevent the drug from accumulating in the body.


Q: Is it possible to develop a tolerance to Herpin over time?

A: Official documents discuss the potential for the virus itself to develop reduced sensitivity (resistance) to Herpin, especially in patients with weakened immune systems who undergo long or repeated treatment courses. The primary concern discussed in regulatory information is viral resistance, not a physical tolerance by the body to the drug's effect.


Q: What age group is Herpin generally described as being for?

A: Herpin is an approved and indicated treatment for use in both adults and pediatric patients (children) for the management of various herpes virus infections.


Q: How do I know if I am eligible to take Herpin?

A: Official regulatory documents define eligibility by listing absolute contraindications, such as a known allergy to aciclovir, valaciclovir, or any component of the formulation. They also note special requirements, such as the need for dosage adjustments for patients with impaired kidney function.


Q: What are the official guidelines regarding maximum use duration for Herpin?

A: Official guidelines set defined durations for acute treatments, typically 5 -10 days. For long-term suppressive therapy against recurrent infections, official documents describe that studies have examined continuous use for periods ranging from 4 months up to 10 years.

How should Herpin be stored and disposed of?

Storage and Disposal Requirements for Herpin (Aciclovir)

Official regulatory documents define the mandatory conditions for storing and disposing of Herpin (Aciclovir).

Item Storage or Disposal Condition
Temperature Store at a controlled room temperature, typically between 15 C and 25 C (59 F to 77 F).
Protection Keep in the original container, tightly closed, and protected from moisture. The oral suspension must not be frozen.
Child Safety The medicine must be kept out of the sight and reach of children.
Disposal Do not dispose of unused or expired medicine via wastewater or household waste. Disposal must follow local regulations, often requiring return to a pharmacy.
Stability Do not use the product after the expiration date. Any unused portions of prepared intravenous solution must be immediately discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Herpin found in:

A-Z Index: